Inspire Medical Systems, Inc. (INSP)
NYSE: INSP · Real-Time Price · USD
83.43
-1.58 (-1.86%)
Nov 5, 2025, 3:54 PM EST - Market open
Inspire Medical Systems Revenue
Inspire Medical Systems had revenue of $224.50M in the quarter ending September 30, 2025, with 10.49% growth. This brings the company's revenue in the last twelve months to $882.62M, up 16.81% year-over-year. In the year 2024, Inspire Medical Systems had annual revenue of $802.80M with 28.49% growth.
Revenue (ttm)
$882.62M
Revenue Growth
+16.81%
P/S Ratio
2.85
Revenue / Employee
$708,364
Employees
1,246
Market Cap
2.42B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 802.80M | 178.01M | 28.49% |
| Dec 31, 2023 | 624.80M | 216.94M | 53.19% |
| Dec 31, 2022 | 407.86M | 174.46M | 74.75% |
| Dec 31, 2021 | 233.39M | 118.01M | 102.28% |
| Dec 31, 2020 | 115.38M | 33.33M | 40.62% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 56.50B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.11B |
INSP News
- 1 day ago - These Analysts Cut Their Forecasts On Inspire Medical Systems Following Q3 Results - Benzinga
- 1 day ago - Baron Discovery Fund Q3 2025 Contributors And Detractors - Seeking Alpha
- 1 day ago - Inspire Medical Systems, Inc. (INSP) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 1 day ago - Inspire Medical Systems, Inc. Announces Third Quarter 2025 Financial Results and Updates 2025 Outlook - GlobeNewsWire
- 8 days ago - Impax Small Cap Fund Q3 2025 Contributors And Detractors - Seeking Alpha
- 9 days ago - Inspire Medical Systems, Inc. to Present at the 2025 UBS Global Healthcare Conference - GlobeNewsWire
- 24 days ago - BAK Investors Have Opportunity to Join Braskem S.A. Fraud Investigation with the Schall Law Firm - Business Wire
- 26 days ago - Inspire Medical Systems, Inc. Publishes Inspire V Data at ISSS/AAO-HNS Meetings - GlobeNewsWire